A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer ...

(HealthDay News) — One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to 2 doses for protecting against HPV16 and HPV18 infection, according to a study published ...

A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical cancer.

A new study has found that just one dose of the HPV vaccine may work as well as two doses to protect against the virus that ...

HPV vaccines have been authorised in the European Union since 2006. View on euronews ...

Introduction Human papillomavirus (HPV) affects nearly 85% of sexually active adults during their lifetime and is responsible for HPV-related cancers in both males and females. Although the HPV ...

Merck MRK continues to face challenges with Gardasil, its second-largest product, which is a vaccine approved for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s ...

Vaccination against a common virus that causes cervical cancer is highly effective, new research shows, providing welcome evidence for health-care providers as they try to counter misinformation ...

Emerging trends in the peer-reviewed scientific literature show new evidence of unintended effects of two popular vaccines—the Human Papilloma Virus (HPV) and shingles vaccines. Surprising findings ...

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck & Co. Inc. (NYSE:MRK) is the ...

Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its Neutral rating on Merck & Co., Inc. (NYSE:MRK) with a fixed ...